The cardiac rehabilitation market is expected to reach US$ 2,865.42 million by 2028 from US$ 1,780.98 million in 2020; it is estimated to grow at a CAGR of 6.2% during 2021–2028.
The cardiac rehabilitation market is expected to reach US$ 2,865.42 million by 2028 from US$ 1,780.98 million in 2020; it is estimated to grow at a CAGR of 6.2% during 2021–2028.
Cardiac rehabilitation devices are used by patients suffering from heart diseases. Various types of cardiac rehabilitation devices available in the market are heart rate monitors, stabilization balls, treadmills, rowers, and elliptical trainers. These rehabilitation devices aid the patients in reducing the danger of heart attacks and heart diseases. Counseling sessions, psychosocial interventions, physical activity counseling, nutritional counseling, hypertension, diabetes & weight management, and exercise are among the activities that aid in monitoring a patient’s disease. The growth of the cardiac rehabilitation market is attributed to the factors such as rising incidence of cardiovascular diseases and growing adoption of tele-cardiac rehabilitation. However, the high cost of cardiac rehabilitation equipment hinders the market growth.
Request for Sample of Cardiac Rehabilitation Market to know which pharma-biotech company is expected to be at the forefront in the coming years @ https://www.theinsightpartners.com/sample/TIPHE100000851/
Some of the Prominent/Emerging Players in Cardiac Rehabilitation Market:
Halma plc; OMRON Corporation; AVECINNA; Koninklijke Philips N.V.; General Electric Company; Core Health & Fitness, LLC; Peloton Interactive, Inc.; Resideo Technologies, Inc; ergoline GmbH; and HealthCare International are among the leading companies operating in the cardiac rehabilitation market.
Key Questions regarding Current Cardiac Rehabilitation Market Landscape
- What are the current options for Cardiac Rehabilitation Market?
- How many companies are developing for the Cardiac Rehabilitation Market?
- What are the key collaborations (Industry-Industry, Industry-Academia), Mergers and acquisitions, and significant licensing activities that will impact the Cardiac Rehabilitation market?
- Which are the dormant and discontinued products and the reasons for the same?
- What is the unmet need for current Cardiac Rehabilitation Market?
- What are the current novel therapies, targets, mechanisms of action, and technologies developed to overcome the limitation of existing Cardiac Rehabilitation?
- What are the critical designations that have been granted for Cardiac Rehabilitation Market?
Based on application, the cardiac rehabilitation market is segmented into angioplasty, coronary artery disease, cardiomyopathy, cholesterol management, diabetes, and lung transplant. The angioplasty segment held the largest market share in 2020 and is expected to retain its dominance during the forecast period. The increasing number of angioplasties is contributing to the market growth for this segment. For instance, as per the AHA 2019 Heart Disease and Stroke Statistics, around 480,000 patients underwent percutaneous coronary intervention (PCI) in the US in 2014.
For example, smoking rates have dropped and treatment rates for cardiovascular disease have increased factors that have made the disease less fatal. At the same time, Americans’ average body mass index and prevalence of diabetes have augmented as the population continues to have made the CVD more prevalent. The prevalence of lifestyle diseases such as hypertension, obesity, dyslipidemia, and diabetes, which are major risk factors for CVD, is also rising. As per the WHO data, more than 1.9 billion adults globally were overweight and over 600 million people were obese in 2016. It is projected that nearly 41% of the world’s population will be overweight or obese by 2030.
Heart disease has endured an important cause of death at the global level for the past 20 years. However, it is now ruining the life of more people than ever before. The change in lifestyles such as smoking, alcohol consumption, and unhealthy food habits is creating heart problems and increasing incidence of lifestyle-associated diseases such as diabetes, cardiovascular diseases, and obesity. Moreover, WHO in 2020 revealed that deaths due to heart disease have grown by over 2 million from 2000 to roughly 9 million in 2019. Majority of deaths due to heart disease were associated with ischemic heart disease and stroke.
Download sample PDF Report Copy at: https://www.theinsightpartners.com/sample/TIPHE100000851/
Cardiac Rehabilitation Market – by Product
- Heart Rate Monitor
- Stabilization Balls
- Treadmill
- Rower
- Elliptical Trainer
- Blood Pressure Monitor
- Stationary Bicycle
Cardiac Rehabilitation Market – by Application
- Angioplasty
- Coronary Artery Disease
- Cardiomyopathy
- Cholesterol Management
- Diabetes
- Lung Transplant
Cardiac Rehabilitation Market – by Distribution Channel
- Hospitals & Clinics
- Specialty Hospitals
- Home Healthcare
- Cardiac Rehabilitation Centers
Interested in Purchasing this Report? Click here @ https://www.theinsightpartners.com/buy/TIPHE100000851/
About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Healthcare, Manufacturing, Automotive and Defense, Food & beverage, Chemical and Materials, Semiconductors. Etc.
Contact Us:
Call: +1-646-491-9876
Email: sales@theinsightpartners.com